Nanoparticle radiosensitization via local quality

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current radiotherapy techniques face limitations in spatial quality and precision of dose delivery, leading to suboptimal cancer treatment outcomes due to the presence of radioresistant hypoxic cells and cells in the S-phase, which require increased radiation doses, thereby risking damage to healthy tissues.

Innovation Solution

The use of biocompatible nanoparticles that localize within cancer cells to alter cell regulatory mechanisms, making them more susceptible to chemotherapeutic agents or ionizing radiation by impairing DNA damage repair mechanisms, thereby enhancing the effectiveness of chemotherapy and radiotherapy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If increased radiation doses are delivered to damage radioresistant cancer cells, then cancer cell death is improved, but damage to normal healthy tissue increases

Engineering Contradiction:
Improvecancer cell deathVSAvoiddamage to healthy tissue
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by introducing nanoparticles with high atomic number elements (such as gold, platinum, or bismuth) specifically into cancer cells. These nanoparticles concentrate radiation absorption locally within the cancer cells, creating a highly localized enhancement of radiation dose. This allows the radiation dose to be enhanced at the target cancer cells while minimizing radiation exposure to surrounding healthy tissues, thereby resolving the contradiction between improving cancer cell death and reducing damage to healthy tissue

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent uses nanoparticles as an intermediary substance that mediates between the incident radiation and the cancer cells. The nanoparticles act as radiation transducers, converting incident radiation into localized energy deposition within the cancer cells. This intermediary mechanism allows for selective enhancement of radiation effects in cancer cells without proportionally increasing the dose to healthy tissues, thus resolving the harmful effect contradiction

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If hardware developments are made to improve spatial quality and precision of dose delivery, then radiation dose precision is improved, but treatment effectiveness plateaus

Engineering Contradiction:
Improvespatial quality and precision of dose deliveryVSAvoidtreatment effectiveness
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent fundamentally changes the parameter of radiation interaction by introducing high atomic number elements into cancer cells. Instead of merely improving the physical delivery system, it alters the interaction parameter between radiation and matter at the cellular level. This parameter change enables significantly enhanced radiation absorption and energy deposition within cancer cells, providing a new mechanism to improve treatment effectiveness beyond what hardware developments alone can achieve

Inventive Principle:
Principle #35Parameter changes

3Use of energy by moving object

If nanoparticles of high atomic weight elements are used to enhance radiation dose locally, then radiation dose enhancement at target is improved, but understanding of cell radiobiological response is insufficient

Engineering Contradiction:
Improveradiation dose enhancementVSAvoidunderstanding of cell radiobiological response
Core Design Contradiction:
Use of energy by moving objectVSLoss of information

Solution Approach 1:

The patent incorporates feedback mechanisms to address the knowledge gap in cell radiobiological response. By systematically studying and measuring the cellular responses to nanoparticle-enhanced radiation, the research establishes feedback loops that refine the understanding of radiation-biological interactions. This feedback enables optimization of nanoparticle types, concentrations, and radiation parameters to achieve desired therapeutic outcomes while minimizing side effects

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach potentiates chemotherapy and radiotherapy by increasing DNA strand breaks in cancer cells, leading to improved treatment outcomes with reduced toxicity to healthy tissues and enhanced cancer cell death, as demonstrated by improved survival rates and reduced metastatic burden in animal models.

Implementation Method 1

the enhancement of radiation doses using high Z element nanoparticles has been attributed to a photoelectric effect mechanism whereby the incident energy is absorbed by an electron within the element and the electron ejected from its orbit

Methodology Applied
Scientific EffectPhotoelectric effect: Photoelectric Effect

Implementation Method 2

nanoparticle radiosensitization may enhance the generation of reactive oxygen species and subsequent damage to DNA to lead to cell death

Methodology Applied
Scientific EffectRadiation-induced reactive oxygen species generation: Radiation

Data Source

PatentUS20230414528A1Nanoparticle cancer therapy
Publication Date: 2023.12.28 ADELAIDE UNIVERSITY
  • US20230414528A1 patent drawing
  • US20230414528A1 patent drawing
  • US20230414528A1 patent drawing

AI summary

Methods of potentiating chemotherapy or radiotherapy are disclosed. The methods comprise administering to a subject in need of chemotherapeutic or radiotherapeutic treatment an effective amount of a composition comprising biocompatible nanoparticles under conditions in which the nanoparticles alter one or more cell regulatory mechanisms in cells in which the nanoparticles are localised or other cells. Then one or more doses of a chemotherapeutic or radiotherapeutic treatment are administered to the subject either concurrently with or after the nanoparticles have altered the one or more cell regulatory mechanisms in the cells in which the nanoparticles are localised or other cells. Also disclosed are methods of enhancing the effects of chemotherapy or radiotherapy on a cell population, methods of increasing the amount of strand breaks in DNA in a cell, and methods of inducing cancer cell death.